FDA Accepts Byondis' Biologics License Application for [Vic-

/PRNewswire/ -- Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company creating precision medicines, announced today that the U.S. Food &...

Related Keywords

Netherlands , Nijmegen , Gelderland , Dutch , Prnewswire Byondis , Marco Timmers , Trastuzumab Duocarmazine , Cherney Kristeen , Jan Schellens , Drug Technology , Us Food Drug Administration , Submission Follows Positive Results , Byondis Technologies Aimed , Improving Treatment Outcomes , Drug Administration , Biologics License Application , Prescription Drug User Fee Act , Byondis Chief Medical Officer Jan Schellens , Next Generation Antibody Drug , Byondi Distinctive , Proprietary Linker Drug , Good Manufacturing Practice , Positive Breast , Understanding Your Outlook , Byondisbv ,